Disclosures: Dr. Dotan has disclosed receiving grant/research support from AstraZeneca Pharmaceuticals LP, Boston Biomedical, Eli Lilly and Company, Incyte Corporation, Ipsen, MedImmune Inc., and Pfizer Inc.
Funding: Dr. Dotan is supported by a Cancer Center Support Grant 3 P30 CA006927.